6'-(R)-Methyl-paromamine
ID: ALA1165271
PubChem CID: 46907084
Max Phase: Preclinical
Molecular Formula: C13H27N3O7
Molecular Weight: 337.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
ID: ALA1165271
PubChem CID: 46907084
Max Phase: Preclinical
Molecular Formula: C13H27N3O7
Molecular Weight: 337.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](O)[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C13H27N3O7/c1-3(17)11-10(21)8(19)6(16)13(22-11)23-12-5(15)2-4(14)7(18)9(12)20/h3-13,17-21H,2,14-16H2,1H3/t3-,4+,5-,6+,7-,8+,9+,10-,11+,12+,13+/m0/s1
Standard InChI Key: WCWFAVKENOLGNG-ZDDMDELRSA-N
Molfile:
RDKit 2D 25 26 0 0 0 0 0 0 0 0999 V2000 11.8717 -18.5581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.8709 -19.3823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.5862 -19.7932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.2956 -19.3837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.2983 -18.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.5811 -18.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.0142 -18.1451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 12.5853 -20.6175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.1572 -19.8039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.4418 -19.3890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4447 -18.5613 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.7331 -18.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0140 -18.5634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0149 -19.3877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7346 -19.8060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7315 -17.3225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.1483 -18.9672 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 9.0190 -16.9075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4410 -17.7252 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 14.0138 -19.8000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.1569 -18.1493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 9.7351 -20.6302 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8.2999 -19.8025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.3006 -18.1482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.4487 -16.9070 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5 6 1 0 5 7 1 1 3 8 1 1 2 9 1 6 9 10 1 0 10 11 1 0 10 15 1 0 11 12 1 0 12 13 1 0 13 14 1 0 14 15 1 0 12 16 1 0 10 17 1 1 16 18 1 6 12 19 1 6 1 2 1 0 1 6 1 0 2 3 1 0 3 4 1 0 4 5 1 0 15 22 1 6 14 23 1 1 1 21 1 1 13 24 1 6 4 20 1 6 16 25 1 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 337.37 | Molecular Weight (Monoisotopic): 337.1849 | AlogP: -4.69 | #Rotatable Bonds: 3 |
Polar Surface Area: 197.67 | Molecular Species: BASE | HBA: 10 | HBD: 8 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.63 | CX Basic pKa: 9.15 | CX LogP: -4.77 | CX LogD: -7.76 |
Aromatic Rings: ┄ | Heavy Atoms: 23 | QED Weighted: 0.25 | Np Likeness Score: 1.86 |
1. Nudelman I, Glikin D, Smolkin B, Hainrichson M, Belakhov V, Baasov T.. (2010) Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations., 18 (11): [PMID:20409719] [10.1016/j.bmc.2010.03.060] |
Source(1):